The Mount Sinai Journal of Medicine

 


Volume 68 Number 1
January 2001
back to contents

The Key Extended Entry Program:
A Methadone Treatment Program for Opiate-Dependent Inmates
14-20
Vincent Tomasino, Arthur J. Swanson, Ph.D., James Nolan, and Harry I. Shuman, M.D., M.P.H.
Address correspondence to Vincent Tomasino, CASAC, 15-15 Hazen Street, East Elmhurst, NY 11370. Attn. CIFM-KEEP.

ABSTRACT
The Key Extended Entry Program (KEEP) is the only known methadone treatment program for incarcerated opiate-dependent inmates in the United States. Initiated in 1987, KEEP performs approximately 18,000 detoxifications and 4,000 admissions for methadone treatment per year. Of those methadone treatment patients discharged to the community, mostly to outpatient KEEP programs, 74–80% report to their designated program. Recidivism rates reveal that 79% of KEEP patients were incarcerated again only once or twice during a recent 11-year period. Finally, KEEP data point to the importance of dedicating slots in the community for released inmates and maintaining them on sufficient blocking doses to eliminate the craving for heroin. About 6% of KEEP patients, some with mental illness have a high incidence of recidivism.

KEY WORDS
Methadone, correctional treatment, jail, discharge planning, recidivism


Mount Sinai School of Medicine MSSM Home Back Issues | Indexes | Search | Journal Home [title]